Founded by brigham and women's hospital and massachusetts general hospital

Office of Continuing Professional Development

Introduction to In Vivo Microscopy (IVM) Interpretation for the Practicing Pathologist

IVM course registration logo2.jpg

Saturday, November 22, 2014
8:30 AM - 5:00 PM

Richard B. Simches Research Center
Massachusetts General Hospital
Rooms 3110, 3120 and 3130
185 Cambridge Street
Boston, MA 02114

Activity Description

This is the first course on IVM designed specifically for pathologists. This live introductory offering will teach attendees the basics of IVM interpretation in clinical settings, and present pathologists with the skills needed to implement this technology in their practices.

Learning Objectives

Upon completion of this activity, participants will...

  • -Be familiar with IVM technologies and terminologies used in IVM image characterization,

  • -Have developed and demonstrated proficiency in the criteria-based interpretations of clinical IVM image series,

  • -Recognize pathology's role in IVM programs and the approaches necessary to ensure its participation therein, and

  • -Recognize and be able to execute the steps needed to implement clinical IVM programs.

Target Audience

This course is designed for practicing pathologists and pathology residents interested in establishing their presence in IVM. Additional participants will include pathology scientists, as well as early adopting clinicians or clinicians hoping to start an IVM program.



 Breakfast arrives; same-day registration opens 


Welcome and overview lecture


Gary Tearney, M.D. Ph.D.


IVM technologies, lecture and live tethered-capsule demo 


Gary Tearney, M.D. Ph.D.


IVM of the upper gastrointestinal tract, lecture with real-time audience response system


Gary Tearney, M.D. Ph.D. and Gregory Lauwers, M.D.




IVM of the lower gastrointestinal tract, lecture with real-time audience response system 


Gregory Lauwers, M.D.


Panel discussion about morning sessions 


Gregory Lauwers, M.D. and Gary Tearney, M.D. Ph.D.


Lunch; breakout sessions on establishing pathology presence in clinical/investigational IVM programs 


2/3 groups, 1/2 clinicians/group, 1/2 pathologists/group


Panel discussion about breakout sessions


IVM compensation considerations for 2015


Jonathan Myles, M.D.


IVM of the cardiovascular system, lecture with real-time audience response system 


Renu Virmani, M.D.




IVM of the skin, lecture with real-time audience response system


Gary Tearney, M.D. Ph.D.


IVM of the bronchial tree, lecture with real-time audience response system


Lida Hariri, M.D. Ph.D.


Panel discussion about afternoon sessions


Lida Hariri, M.D. Ph.D.; Jonathan Myles, M.D.; Renu Virmani, M.D.; and Gary Tearney, M.D. Ph.D.




Sample examination


image-based multiple choice questions with real-time audience response system




Dr. Gary Tearney has been a pioneer in the development and validation of technologies in the field of in vivo microscopy (IVM).  He earned his MD from Harvard Medical School (HMS) and his PhD in electrical engineering from the Massachusetts Institute of Technology.  Dr. Tearney trained in pathology at the Massachusetts General Hospital (MGH).  He is currently on faculty in the pathology department at the MGH and is a professor of pathology at HMS.  He also serves as vice-chair of the College of American Pathologists’ IVM Committee.

Dr. Gregory Lauwers has spearheaded numerous confocal laser endomicroscopy initiatives in the gastrointestinal tract.  He earned his MD from the University of Paris VII.  Dr. Lauwers trained in pathology at Lenox Hill Hospital and Memorial Sloan-Kettering Cancer Center.  He is currently on faculty in the pathology department at MGH and is a professor of pathology at HMS.  He is an active member of the College of American Pathologists’ IVM Committee.

Dr. Renu Virmani is an internationally renowned researcher in the field of cardiovascular disease treatments.  She earned her MD from Lady Hardinge Medical College of Delhi University.  She serves as President and Medical Director of CVPath Institute, which she founded in 2005, and is also a professor of pathology at Georgetown University, the University of Maryland-Baltimore, George Washington University and Vanderbilt University.

Dr. Jonathan Myles is a national leader in pathology payment policy. He graduated from the Medical College of Ohio and completed his pathology training at Cleveland Clinic.  He is currently the director of the medical kidney service at Cleveland Clinic.  Dr. Myles also serves as a member of the American Medical Association (AMA) Physician Consortium for Performance Improvement - Pathology Work Group, the Pathology Advisor to the AMA-Relative Value Update Committee and Chair of the Economic Affairs Committee of the College of American Pathologists.

Dr. Lida Hariri is active in investigational inroads for IVM in the bronchial tree.  She earned her MD and PhD in biomedical engineering, both from the University of Arizona.  Dr. Hariri trained at MGH, where she is currently a pulmonary pathologist in addition to her research commitments.  She is also an active member of the College of American Pathologists’ IVM Committee.

Registration Fees

CAP Members: $300

CAP Junior Members: $50

Other Clinician Attendees: $390

Other Resident Attendees: $100

Note: Attendees will save 20% if they register by August 29th and 10% if they register by September 29th.

Additional Requests

For assistance with any special needs (i.e., physical, dietary, etc) please contact Dr. Andrew Quinn prior to the live event at MGHIVMCOURSE@PARTNERS.ORG

Provided by:

Massachusetts General Hospital, Department of Pathology, and Partners HealthCare


IVM course registration logo2.jpg founding_member.png



CME Information

Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.